Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Liquid Biopsy is Cost-Effective for Biopsy Selection in prostate cancer

MDxHealth today announced BJU International published a study demonstrating that its SelectMDx for Prostate Cancer test can reduce overdiagnosis a…


MITHRA RECEIVES GMP APPROVAL FOR MYRING™ PRODUCTION

With production GMP approved, Mithra's Myring contraceptive is well on schedule to storm the markets within less than a year.


MDx Health's SelectMDx to be Distributed Across Middle East by IPS Genomix

MDx Health gains market access of the Middle East via partner IPS Genomix.

POPULAR TAGS

Inception of anaRIC biologics as Anacura and RIC combine R&D and GMP activities

Written by LVS on in the category news with the tags .


With the purpose of supporting customers throughout their entire biological drug development process, GMP specialist Anacura and the R&D-focused RIC have initiated a collaboration under the moniker ‘anaRIC biologics’.

anaRIC biologics is a contract research organization (CRO) specialized in the analysis of complex, biological compounds, such as antibodies, proteins and peptides. These innovative products differ drastically from classical, small molecules and require a different set of skills to analyze. With 15 years of GMP and 30 years of R&D experience, anaRIC biologics is able to support this rapidly growing market segment throughout the entire drug development process.

Koen Sandra, Scientific Director of the Research Institute for Chromatography (RIC): “Given their complexity and heterogeneity there is a clear need for analytical expertise in the domain of biological molecules. Different phases during development translate into different needs. By combining RIC’s flexible and innovative R&D with Anacura’s standardized and stable GMP environment we are able to create a highly complementary collaboration accentuating our strengths."

Griet Nuytinck, Managing Director at Anacura: “Whether you are talking about product lead selection, manufacturing or analytical testing, choosing the right partner to bring your biological product to market is of strategic importance. Through our R&D/GMP partnership, anaRIC biologics becomes your reference CRO for analytics of biological molecules from discovery to marketing."

Read more about: .

RELATED ARTICLES
Liquid Biopsy is Cost-Effective for Biopsy Selection in prostate cancer

MDxHealth today announced BJU International published a study demonstrating that its SelectMDx for Prostate Cancer test can reduce overdiagnosis a…


MITHRA RECEIVES GMP APPROVAL FOR MYRING™ PRODUCTION

With production GMP approved, Mithra's Myring contraceptive is well on schedule to storm the markets within less than a year.


MDx Health's SelectMDx to be Distributed Across Middle East by IPS Genomix

MDx Health gains market access of the Middle East via partner IPS Genomix.

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Flanders.bio Biowin XpandInnovation V-Bio Ventures Turnstone Janssen Itera Life Science KU Leuven GSK UGent

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.